Nrf2-activator-21-生命科學(xué)試劑-MCE_第1頁(yè)
Nrf2-activator-21-生命科學(xué)試劑-MCE_第2頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

Hotline:400-820-3792Inhibitors ? ScreeningLibraries ? Proteinswww.MedChemENrf2activator-21Cat.No.:HY-175548CASNo.:1912404-14-8分子式:C??H??O?分子量:322.31作用靶點(diǎn):Keap1-Nrf2;Apoptosis;Caspase作用通路:NF-κB;Apoptosis儲(chǔ)存方式:PleasestoretheproductundertherecommendedconditionsintheCertificateofAnalysis.BIOLOGICALACTIVITY生物活性Nrf2activator-21是一種具有雙重抗氧化和神經(jīng)保護(hù)特性的Nrf2激活劑。Nrf2activator-21與Keap1Kelch結(jié)構(gòu)域結(jié)合,破壞Keap1-Nrf2相互作用,并激活抗氧化防御機(jī)制。Nrf2activator-21減少海馬神經(jīng)元的凋亡(apoptosis)并降低caspase-3活性。Nrf2activator-21通過(guò)激活Nrf2途徑靶向腦缺血/再灌注損傷(CIRI)。Nrf2activator-21改善神經(jīng)功能,緩解大鼠雙血管閉塞(2VO)誘導(dǎo)的CIRI的焦慮樣行為,并增強(qiáng)記憶。Nrf2activator-21可用于腦缺血/再灌注損傷研究[1]。體外研究Nrf2activator-21(Compound7I)(1-15μM,24h)significantlyimprovestheviabilityofhippocampalneuronalcellsexposedtoH2O2[1].Nrf2activator-21(2.5μM,24h)reducesapoptosisanddecreasescaspase-3activityinthehippocampalneurons[1].ApoptosisAnalysis[1]CellLine:hippocampalneuronsConcentration:2.5μMIncubationTime:24hResult:Reducedapoptosisanddecreasedcaspase-3activityinthehippocampalneurons.體內(nèi)研究Nrf2activator-21(Compound7I)(15mg/kg,i.p.,once,15minpost-reperfusion)significantlyimprovesneurologicalfunctioninmaleadultWistarratswith2-vesselocclusion(2VO)-inducedcerebralischemia/reperfusioninjury[1].1/2 MasterofBioactiveMolecules—您身邊的抑制劑大師www.MedChemEAnimalModel:MaleadultWistarrats:amidlineneckincisionwasmadetoisolatebilateralcommoncarotidarteries,whichwerethenclampedsimultaneouslyfor15mintoinducecerebralischemia,followedby15minofreperfusiontoestablishthe2-vesselocclusion(2VO)cerebralischemia/reperfusioninjurymodel[1]Dosage:15mg/kgAdministration:i.p.once15minpost-reperfusionResult:Achievedsignificantimprovementsinmotorfunction,sensoryresponse,andwirecageclimbingability,withtotalneurologicaldeficitscoresnotablyreducedin2VOmodelrats.Showedalleviationofanxiety-likebehavior.Improvedmemoryfunction,withthediscriminationindexsignificantlyincreasedintheNovelObjectRecognitionTest,reversingmemorydeficitsinducedbycerebralischemia/reperfusioninjury.PreservedhippocampalCA1neuronmorphologyandreducedthenumberofdegenerateddarkneuronsanddecreasedhippocampalcaspase-3activity.IncreasedhippocampalNrf2proteinexpression,restoredSODandCATactivitiestonear-shamlevelsandreducedMDAlevels.UpregulatedhippocampalBDNFandTrkBreceptorlevelsandenhancedneuroprotectivesignaling.REFERENCESMohammadniaM,etal.Coumarin-Chalconederivativesaspromisingantioxidantagentstargetingischemia/reperfusioninjurythroughNrf2pathwayactivation.BioorgChem.2025Jul26;164:108790.McePdfHeightCaution:Producthasnotbeenfullyvalidatedformedicalappli

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論